Integra Lifesciences PE ratio IART

Share price divided by earnings per share over the last twelve months, since 2011.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 66.5×; Nov 2024
10-year median: 46.1×
10-year range: 18.7× to 179×
Peer median: 30.1×

Integra Lifesciences has no meaningful PE ratio today: it lost $0.09 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Nov 2024, at 66.5×.

On the days it had one over the last ten years, its median was 46.1×, from 18.7× in May 2023 to 179× in Jun 2020.

PE ratio over time

median 46.1×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2024	66.5×	33.2×	82.9×
2023	36.0×	18.7×	36.9×
2022	27.2×	21.4×	34.1×
2021	26.4×	24.7×	103×
2020	96.9×	65.2×	179×
2019	85.0×	44.8×	90.2×
2018	44.8×	44.8×	88.6×
2017	78.5×	34.3×	82.8×
2016	42.5×	37.5×	42.5×
2015	48.8×	46.4×	61.4×
2014	58.0×	50.6×	58.0×
2013	49.3×	22.6×	50.0×
2012	33.3×	17.2×	48.5×
2011	21.7×	20.4×	26.5×

Against its peers

Companies in Medical - Instruments & Supplies nearest Integra Lifesciences' size, closest first, today.

Company	PE ratio
IARTIntegra Lifesciences	n/m
IRMDIradimed	47.9×
STAAStaar Surgical	323×
MOVMovado	17.5×
BVSBioventus	19.4×
CDRECadre	37.0×
EYENational Vision	30.6×
MDXGMimedx	97.8×
TCMDTactile Systems Technology	21.9×
LMATLemaitre Vascular	29.6×
INSPInspire Medical Systems	15.4×
Peer median	30.1×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Integra Lifesciences

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.